Efficacy of magnesium-calcium ionic oral rinse for primary burning mouth syndrome: a randomized, double-blind, placebo-controlled trial.

TL;DR

A randomized controlled trial found that a magnesium-calcium oral rinse reduced burning mouth pain by 1.7 points on a 10-point scale compared to placebo over 8 weeks , with 62% of users reporting meaningful improvement versus 32% on placebo. This is the first controlled evidence for a topical mineral-ionic approach to primary burning mouth syndrome, though the mechanism and long-term durability remain unclear.

What the Study Found

Burning mouth syndrome is a chronic pain condition affecting roughly 1-2% of the population, predominantly women in midlife. Patients experience a persistent burning or scalding sensation in the mouth, tongue, or lips without visible tissue damage. Current treatments often rely on systemic medications like tricyclic antidepressants or anticonvulsants, which carry side effects that limit tolerability. This trial tested a different approach: directly modulating the ionic chemistry of the oral mucosa with a topical rinse containing magnesium and calcium ions.

The study enrolled 116 adults with primary burning mouth syndrome and randomized them to use either an active magnesium-calcium rinse or placebo three times daily for 8 weeks. The primary outcome was burning pain intensity measured on a Numeric Rating Scale (0-10). At week 8, the active group showed a mean reduction of 1.7 points greater than placebo (95% confidence interval, -2.5 to -0.9; P<0.001). To put this in perspective, a 2-point reduction on the NRS is often considered clinically meaningful in pain research. Responder rates reflected this: 62% of participants in the active group achieved at least a 2-point improvement compared to 32% in the placebo group (P=0.001).

Secondary outcomes reinforced these findings. Quality of life improvements measured by the Oral Health Impact Profile-14 showed significant gains in the active group. Xerostomia (dry mouth) scores also improved meaningfully, which is relevant since mouth dryness is both a symptom of and potential driver of burning mouth syndrome. The Patient Global Impression of Change scale indicated that participants assigned to active rinse were more likely to report subjective improvement. Adverse events were mild and balanced across both groups, suggesting a favorable safety profile for this intervention.

The mechanism underlying benefit remains incompletely understood. The hypothesis centers on the neuropathic basis of primary burning mouth syndrome, where altered ion channel function and peripheral nerve sensitization drive pain signaling. Magnesium and calcium play roles in modulating neuronal excitability and neuropathic pain in other contexts. A topical approach allows direct contact with mucosal tissues without systemic absorption, potentially minimizing side effects compared to oral medications. However, the study did not measure biomarkers, nerve function, or ionic concentrations in saliva, so whether clinical improvement reflects actual changes in mucosal ionic microenvironment remains speculative.

What This Means for You

If you experience chronic burning mouth sensation without visible mucosal disease, this trial adds a potential option to discuss with your healthcare provider. The effect size (1.7-point reduction) is modest but meaningful, and a 62% responder rate suggests roughly 2 in 3 people may benefit. The topical route avoids systemic side effects, making it a reasonable first-line experimental approach before escalating to oral medications.

Important caveats: this is a single trial in a relatively small sample, and results have not yet been independently replicated. The 8-week observation period tells us about short-term efficacy but not long-term durability or whether benefit persists after stopping the rinse. The study was retrospectively registered (noted after the enrollment period began), which raises methodological questions about whether primary outcomes were pre-specified or modified after seeing data trends. Approximately 32% of placebo users improved, reflecting the substantial placebo response in pain conditions, so careful interpretation of active versus placebo differences is warranted.

If you pursue this approach, expect to rinse for 60 seconds, three times daily, and assess response over 6-8 weeks. Because the product is not yet widely available outside research settings, availability may be a limiting factor. Concurrent management of underlying factors (nutritional deficiencies, dry mouth, oral irritation, stress) remains important, as burning mouth syndrome is multifactorial.

Study Details

Sources